Many treatments of DM, including insulin secretagogues, are currently available, but most of them are associated with many unfavorable adverse effects like hypertension, diarrhea, and hypoglycemia (Inzucchi et al., 2016). The gene discussed is INS; the disease is diabetes mellitus.